These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 36016150)

  • 1. Application of mRNA Technology in Cancer Therapeutics.
    Eralp Y
    Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinspired and Biomimetic Delivery Platforms for Cancer Vaccines.
    Liu J; Liew SS; Wang J; Pu K
    Adv Mater; 2022 Jan; 34(1):e2103790. PubMed ID: 34651344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoformulations targeting immune cells for cancer therapy: mRNA therapeutics.
    Yang W; Cao J; Cheng H; Chen L; Yu M; Chen Y; Cui X
    Bioact Mater; 2023 May; 23():438-470. PubMed ID: 36471724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and immunological effects of mRNA vaccines in malignant diseases.
    Heine A; Juranek S; Brossart P
    Mol Cancer; 2021 Mar; 20(1):52. PubMed ID: 33722265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of rational design of mRNA-based therapeutics and vaccines.
    To KKW; Cho WCS
    Expert Opin Drug Discov; 2021 Nov; 16(11):1307-1317. PubMed ID: 34058918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mRNA Vaccines: The Dawn of a New Era of Cancer Immunotherapy.
    Deng Z; Tian Y; Song J; An G; Yang P
    Front Immunol; 2022; 13():887125. PubMed ID: 35720301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticles for nucleic acid delivery: Applications in cancer immunotherapy.
    Mukalel AJ; Riley RS; Zhang R; Mitchell MJ
    Cancer Lett; 2019 Aug; 458():102-112. PubMed ID: 31100411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoscale platforms for messenger RNA delivery.
    Li B; Zhang X; Dong Y
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Mar; 11(2):e1530. PubMed ID: 29726120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mRNA vaccine for cancer immunotherapy.
    Miao L; Zhang Y; Huang L
    Mol Cancer; 2021 Feb; 20(1):41. PubMed ID: 33632261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoscale delivery platforms for RNA therapeutics: Challenges and the current state of the art.
    Rhym LH; Anderson DG
    Med; 2022 Mar; 3(3):167-187. PubMed ID: 35590191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentialities and Challenges of mRNA Vaccine in Cancer Immunotherapy.
    Duan LJ; Wang Q; Zhang C; Yang DX; Zhang XY
    Front Immunol; 2022; 13():923647. PubMed ID: 35711457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid-Based Vectors for Therapeutic mRNA-Based Anti-Cancer Vaccines.
    Guevara ML; Persano S; Persano F
    Curr Pharm Des; 2019; 25(13):1443-1454. PubMed ID: 31258071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer vaccines as promising immuno-therapeutics: platforms and current progress.
    Liu J; Fu M; Wang M; Wan D; Wei Y; Wei X
    J Hematol Oncol; 2022 Mar; 15(1):28. PubMed ID: 35303904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered Nanoparticles for Cancer Vaccination and Immunotherapy.
    Aikins ME; Xu C; Moon JJ
    Acc Chem Res; 2020 Oct; 53(10):2094-2105. PubMed ID: 33017150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging mRNA technologies: delivery strategies and biomedical applications.
    Xiao Y; Tang Z; Huang X; Chen W; Zhou J; Liu H; Liu C; Kong N; Tao W
    Chem Soc Rev; 2022 May; 51(10):3828-3845. PubMed ID: 35437544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview.
    Machado BAS; Hodel KVS; Fonseca LMDS; Mascarenhas LAB; Andrade LPCDS; Rocha VPC; Soares MBP; Berglund P; Duthie MS; Reed SG; Badaró R
    Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and Immunotherapy.
    Fan Y; Moon JJ
    Vaccines (Basel); 2015 Aug; 3(3):662-85. PubMed ID: 26350600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery of nucleic acid therapeutics for cancer immunotherapy.
    Zhou S; Chen W; Cole J; Zhu G
    Med Drug Discov; 2020 Jun; 6():. PubMed ID: 34337382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in mRNA-based drug discovery in cancer immunotherapy.
    Di Trani CA; Fernandez-Sendin M; Cirella A; Segués A; Olivera I; Bolaños E; Melero I; Berraondo P
    Expert Opin Drug Discov; 2022 Jan; 17(1):41-53. PubMed ID: 34496689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.